Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis

doi:10.12998/wjcc.v10.i7.2194

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3918)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

193

WORD

106

HTML

1782

Figures (1-7)

245

Tables (1-2)

297

Sum=2623

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

333

Download

962

Sum=1295

Mar 6, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Mar 6, 2022; 10(7): 2194-2205
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2194

Full Size Figure Download Figure

Figure 4 The association of lymphocyte to monocyte ratio with prognosis of osteosarcoma patients. A: The association of lymphocyte to monocyte ratio with overall survival of osteosarcoma patients; B: The association of lymphocyte to monocyte ratio with disease-free survival of osteosarcoma patients. CI: Confidence interval; HR: Hazard ratio.

Citation: Peng LP, Li J, Li XF. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis. World J Clin Cases 2022; 10(7): 2194-2205
URL: https://www.wjgnet.com/2307-8960/full/v10/i7/2194.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i7.2194